SOPHARMA AD (18/2021) The Board of Directors of "Sopharma" AD adopted a decision to issue warrants

Podstawa prawna: art. 56. 1. 2 of Act on Public Offering.

Sofia, Bulgaria, May 21, 2021 - According to the requirements of art. 100t of LPOS, "Sopharma" AD (SFA: "BSE-Sofia" AD, SPH: Warsaw Stock Exchange) notifies that in accordance with аrt. 25 of the Articles of incorporation of the Company, the Board of Directors adopted a decision for issuance, under the conditions of initial public offering, of warrants as follows:

Exercise value: BGN 4.13

Issuance price of one warrant: BGN 0.28

Number of warrants: 44,932,633

Minimum success threshold of the issue: 22,466,317

Term in which the right can be exercised: 3 years

The remaining parameters of the issue will be described in a Prospectus for Public Offering of warrants, which should be adopted by the Board of Directors with a subsequent decision and should receive the relevant approval from the Financial Supervision Commission.

The consultant and investment intermediary selected by the Board of Directors in connection with the issuance of the warrants are respectively: Main Capital AD, UIC 202402882, with registered office in Sofia, and management address Sofia 1404, Triaditsa District, zh.k. "Gotse Delchev", bl. 22, entrance 2 and MK Brokers AD, UIC 1750070052, with registered office in Sofia and management address, 8, "Tsar Osvoboditel" Blvd.

Więcej na: http://biznes.pap.pl/pl/reports/espi/all,0,0,0,1

kom espi zdz